TAM
BIOL

THB Asset Management’s Biolase, Inc. BIOL Stock Holding History

THB Asset Management’s Portfolio BIOL Stock Details BIOL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-35
Closed -$837K – 283
2013
Q3 		$837K Sell
35
-2
-5% -$64.4K 0.05% 243
2013
Q2 		$1.6M Buy
+37
New +$2.07M 0.11% 209

Other funds holding BIOL

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
PCMI
Princeton Capital Management Inc Princeton, New Jersey $198M AUM 28.98% 1-Year Est. Return
TA
Teton Advisors Rye, New York $173M AUM 77.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

THB Asset Management's BIOL Position: Q4 2013 in Review

THB Asset Management sold out of Biolase, Inc. (BIOL) in Q4 2013, closing a stake of 35 shares — an estimated $837K sold.

THB Asset Management first reported a position in BIOL in Q2 2013 and held it in 2 quarters. The position peaked at $1.6M in Q2 2013. 39 funds tracked by Wall St. Rank hold BIOL as of Q4 2013.

  • THB Asset Management reported no remaining Biolase, Inc. position as of Q4 2013 after selling out during the quarter.
  • THB Asset Management sold 35 Biolase, Inc. shares in Q4 2013, an estimated $837K.
  • THB Asset Management first reported a position in Biolase, Inc. in Q2 2013 and held it in 2 quarters.
  • THB Asset Management's Biolase, Inc. position peaked at $1.6M in Q2 2013.
  • 39 funds tracked by Wall St. Rank held Biolase, Inc. as of Q4 2013.

Based on THB Asset Management's 13F filing for Q4 2013, filed 6 Feb 2014.